This case report and review of the literature highlights the limitations of cold urticaria and the importance of effective management in improving quality of life in affected patients. Symptoms may limit patients’ ability to work in certain environments, inhibit them from engaging in daily activities, and even prevent them from leaving their homes in colder temperatures. In addition to behavioral modifications, pharmacologic management may provide symptomatic relief. Antihistamines are the first line of treatment in cold urticaria. Second-generation antihistamines, which are more selective for H1 receptors and less sedating, are generally recommended. Up to 4 times the standard dosage of these medications may be required for effective treatment.5 The primary goal of therapy in mild to moderate cases is improvement in quality of life.